Hakan Apaydın (Hakan Apaydin)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Interstitial Lung Disease

Systemic Sclerosis

Anterior Cruciate Ligament Reconstruction

Psychometric Properties

Top Venues

Journal of foot and ankle research

Laboratory medicine

Rheumatology (Oxford, England)

Archives of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Nazli Busra Cigercioglu, Zilan Bazancir Apaydin, Hakan Apaydın, Gul Baltaci, Hande Guney-Deniz
Differences in ankle and knee muscle architecture and plantar pressure distribution among women with knee osteoarthritis. Journal of foot and ankle research 17 (2) (2024)
Nazli Busra Cigercioglu, Zilan Bazancir Apaydin, Hakan Apaydın, Gul Baltaci, Hande Guney-Deniz
Differences in ankle and knee muscle architecture and plantar pressure distribution among women with knee osteoarthritis. Journal of foot and ankle research 17 (2) (2024)
Nazli Busra Cigercioglu, Zilan Bazancir Apaydin, Hakan Apaydın, Gul Baltaci, Hande Guney-Deniz
Differences in ankle and knee muscle architecture and plantar pressure distribution among women with knee osteoarthritis. Journal of foot and ankle research 17 (2) (2024)
Fulden Sari, Zilan Bazancir Apaydin, Hakan Apaydın, Mehmet Kayaalp, Abdulsamet Erden, Serdar Can Güven, Armagan Berkan, Ahmet Omma, Orhan Kücüksahin, Şükran Erten
Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis. Archives of rheumatology 39 (1) (2023)
Mehmet Kayaalp, Abdulsamet Erden, Hakan Apaydın, Serdar Can Güven, Armagan Berkan, Merve Cağlayan Kayaalp, Esma Andac Uzdogan, Şeymanur Ala Enli, Ahmet Omma, Orhan Kücüksahin
Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis. Laboratory medicine (2023)
Fulden Sari, Zilan Bazancir Apaydin, Hakan Apaydın, Mehmet Kayaalp, Abdulsamet Erden, Serdar Can Güven, Armagan Berkan, Ahmet Omma, Orhan Kücüksahin, Şükran Erten
Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis. Archives of rheumatology 39 (1) (2023)
Hakan Apaydın, Abdulsamet Erden, Serdar Can Güven, Armagan Berkan, Hatice Ecem Konak, Bünyamin Polat, Yağnur Afşin, Merve Kaygisiz, Ahmet Omma, Orhan Kücüksahin
Effects of anti-SARS-CoV-2 vaccination on safety and disease exacerbation in patients with Behçet syndrome in a monocentric cohort. International journal of rheumatic diseases 25 (9) (2022)
Hakan Apaydın, Cemile Koca Bicer, Emine Feyza Yurt, Muhittin Abdulkadir Serdar, İsmail Dogan, Sukran Erten
Elevated Kynurenine Levels in Patients with Primary Sjögren's Syndrome. Laboratory medicine (2022)
Abdulsamet Erden, Hakan Apaydın, Antonis Fanouriakis, Serdar Can Güven, Berkan Armagan, Pınar Akyüz Dağlı, Hatice Ecem Konak, Bünyamin Polat, Ebru Atalar, Serdar Esmer, Özlem Karakaş, Bahar Özdemir, Mehmet Akif Eksin, Ahmet Omma, Orhan Kücüksahin, George K Bertsias, Dimitrios T Boumpas
Performance of the systemic lupus erythematosus risk probability index in a cohort of undifferentiated connective tissue disease. Rheumatology (Oxford, England) 61 (9) (2022)
Hakan Apaydın, Abdulsamet Erden, Serdar Can Güven, Armagan Berkan, Özlem Karakaş, Bahar Özdemir Ulusoy, Bünyamin Polat, Mehmet Akif Eksin, Ahmet Omma, Orhan Kücüksahin
Clinical course of idiopathic inflammatory myopathies in COVID-19 pandemic: a single-center experience. Future virology (2022)
Hakan Apaydın, Armagan Berkan, Serdar Can Güven, Ahmet Omma, Orhan Kücüksahin, Abdulsamet Erden
Comment on: What is the meaning of ANCA positivity in IgG4-related disease? Rheumatology (Oxford, England) 60 (9) (2021)
Hakan Apaydın, Şükran Erten
Tofacitinib-induced subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis. Modern rheumatology case reports 5 (2) (2021)
Hakan Apaydın, Ismail Dogan, Şükran Erten
Secukinumab can treat psoriasis induced by anti-TNF-alpha therapy in patients with ankylosing spondylitis: Case series. International journal of rheumatic diseases 23 (3) (2020)